Does NEPAFENAC Cause Therapy partial responder? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Therapy partial responder have been filed in association with NEPAFENAC (ILEVRO). This represents 1.4% of all adverse event reports for NEPAFENAC.
24
Reports of Therapy partial responder with NEPAFENAC
1.4%
of all NEPAFENAC reports
0
Deaths
0
Hospitalizations
How Dangerous Is Therapy partial responder From NEPAFENAC?
Of the 24 reports.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NEPAFENAC. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does NEPAFENAC Cause?
Eye pain (393)
Drug ineffective (270)
Treatment failure (208)
Vision blurred (133)
Eye irritation (67)
Visual impairment (66)
Product quality issue (57)
Liquid product physical issue (55)
Off label use (43)
Cystoid macular oedema (42)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which NEPAFENAC Alternatives Have Lower Therapy partial responder Risk?
NEPAFENAC vs NERATINIB
NEPAFENAC vs NETARSUDIL
NEPAFENAC vs NETUPITANT\PALONOSETRON
NEPAFENAC vs NEULASTA
NEPAFENAC vs NEUPOGEN